BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 593079 NC(=N)NCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:27:26:11:21.15.14| InChI=1S/C23H33N5O3/c24-21(25)27-7-6-26-20(30)16-11-22-5-8-28(13-14-1-2-14)19(23(22,31)12-16)9-15-3-4-17(29)10-18(15)22/h3-4,10,14,16,19,29,31H,1-2,5-9,11-13H2,(H,26,30)(H4,24,25,27) ZLARBRFVWKMWNZ-UHFFFAOYSA-N 309329 US9656962, Compound 6::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guanidinoethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Nociceptin receptor Human 10273 US Patent 10.7270/Q2K076BH aid1796242 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309329 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309329&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699182 382365396 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 593080 NC(=N)NCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:27:26:11:21.15.14| InChI=1S/C23H33N5O3/c24-21(25)27-7-6-26-20(30)16-11-22-5-8-28(13-14-1-2-14)19(23(22,31)12-16)9-15-3-4-17(29)10-18(15)22/h3-4,10,14,16,19,29,31H,1-2,5-9,11-13H2,(H,26,30)(H4,24,25,27) ZLARBRFVWKMWNZ-UHFFFAOYSA-N 309329 US9656962, Compound 6::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guanidinoethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 19.7 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309329 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309329&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699182 382365396 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593081 NC(=N)NCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:27:26:11:21.15.14| InChI=1S/C23H33N5O3/c24-21(25)27-7-6-26-20(30)16-11-22-5-8-28(13-14-1-2-14)19(23(22,31)12-16)9-15-3-4-17(29)10-18(15)22/h3-4,10,14,16,19,29,31H,1-2,5-9,11-13H2,(H,26,30)(H4,24,25,27) ZLARBRFVWKMWNZ-UHFFFAOYSA-N 309329 US9656962, Compound 6::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guanidinoethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 0.098 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309329 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309329&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699182 382365396 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593082 NC(=N)NCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:27:26:11:21.15.14| InChI=1S/C23H33N5O3/c24-21(25)27-7-6-26-20(30)16-11-22-5-8-28(13-14-1-2-14)19(23(22,31)12-16)9-15-3-4-17(29)10-18(15)22/h3-4,10,14,16,19,29,31H,1-2,5-9,11-13H2,(H,26,30)(H4,24,25,27) ZLARBRFVWKMWNZ-UHFFFAOYSA-N 309329 US9656962, Compound 6::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guanidinoethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Delta-type opioid receptor Human 7714 US Patent 10.7270/Q2K076BH aid1796245 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309329 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309329&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699182 382365396 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 593083 NC(=N)NCCCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:29:28:13:23.17.16| InChI=1S/C25H37N5O3/c26-23(27)29-9-2-1-8-28-22(32)18-13-24-7-10-30(15-16-3-4-16)21(25(24,33)14-18)11-17-5-6-19(31)12-20(17)24/h5-6,12,16,18,21,31,33H,1-4,7-11,13-15H2,(H,28,32)(H4,26,27,29) KKSGPBODUPPBKK-UHFFFAOYSA-N 309331 US9656962, Compound 7::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(4-guanidinobutyl)-3a,8-dibydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 23.6 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309331 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309331&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699261 382365398 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593084 NC(=N)NCCCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:29:28:13:23.17.16| InChI=1S/C25H37N5O3/c26-23(27)29-9-2-1-8-28-22(32)18-13-24-7-10-30(15-16-3-4-16)21(25(24,33)14-18)11-17-5-6-19(31)12-20(17)24/h5-6,12,16,18,21,31,33H,1-4,7-11,13-15H2,(H,28,32)(H4,26,27,29) KKSGPBODUPPBKK-UHFFFAOYSA-N 309331 US9656962, Compound 7::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(4-guanidinobutyl)-3a,8-dibydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 0.130 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309331 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309331&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699261 382365398 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593085 COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(N)=O)c2c1 |r,TLB:9:8:19:24.5.6| InChI=1S/C21H28N2O3/c1-26-16-5-4-14-8-18-21(25)11-15(19(22)24)10-20(21,17(14)9-16)6-7-23(18)12-13-2-3-13/h4-5,9,13,15,18,25H,2-3,6-8,10-12H2,1H3,(H2,22,24) IOOHMAGDMPHDJV-UHFFFAOYSA-N 309360 US9656962, Compound 11::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a-hydroxy-8-methoxy-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)cyclo- penta[a]naphthalene-2-carboxamide Mu-type opioid receptor Human 2982 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309360&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699251 382365427 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593086 COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(N)=O)c2c1 |r,TLB:9:8:19:24.5.6| InChI=1S/C21H28N2O3/c1-26-16-5-4-14-8-18-21(25)11-15(19(22)24)10-20(21,17(14)9-16)6-7-23(18)12-13-2-3-13/h4-5,9,13,15,18,25H,2-3,6-8,10-12H2,1H3,(H2,22,24) IOOHMAGDMPHDJV-UHFFFAOYSA-N 309360 US9656962, Compound 11::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a-hydroxy-8-methoxy-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)cyclo- penta[a]naphthalene-2-carboxamide Kappa-type opioid receptor Human 182 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309360&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699251 382365427 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593087 COC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,THB:22:21:6:16.10.9| 309366 US9656962, Compound 12::(2R,3aS,4R,9bS)-methyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxylate Mu-type opioid receptor Human 0.530 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309366&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118198024 382365433 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593088 COC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,THB:22:21:6:16.10.9| 309366 US9656962, Compound 12::(2R,3aS,4R,9bS)-methyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxylate Kappa-type opioid receptor Human 0.300 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309366&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118198024 382365433 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593089 OC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H25NO4/c22-15-4-3-13-7-17-20(25)10-14(18(23)24)9-19(20,16(13)8-15)5-6-21(17)11-12-1-2-12/h3-4,8,12,14,17,22,25H,1-2,5-7,9-11H2,(H,23,24) UNYTXCFUSXJNAQ-UHFFFAOYSA-N 309374 US9656962, Compound 16::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)-cyclopenta- [a]naphthalene-2-carboxylic acid Mu-type opioid receptor Human 55.6 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309374&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699170 382365441 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593090 OC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H25NO4/c22-15-4-3-13-7-17-20(25)10-14(18(23)24)9-19(20,16(13)8-15)5-6-21(17)11-12-1-2-12/h3-4,8,12,14,17,22,25H,1-2,5-7,9-11H2,(H,23,24) UNYTXCFUSXJNAQ-UHFFFAOYSA-N 309374 US9656962, Compound 16::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)-cyclopenta- [a]naphthalene-2-carboxylic acid Kappa-type opioid receptor Human 17.3 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309374&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699170 382365441 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593091 NC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H26N2O3/c21-18(24)14-9-19-5-6-22(11-12-1-2-12)17(20(19,25)10-14)7-13-3-4-15(23)8-16(13)19/h3-4,8,12,14,17,23,25H,1-2,5-7,9-11H2,(H2,21,24) ADLPAZXMBFTTEG-UHFFFAOYSA-N 309406 US9656962, Compound 31::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalene-2-carboxamide Nociceptin receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796242 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309406&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699258 382365473 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 593092 NC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H26N2O3/c21-18(24)14-9-19-5-6-22(11-12-1-2-12)17(20(19,25)10-14)7-13-3-4-15(23)8-16(13)19/h3-4,8,12,14,17,23,25H,1-2,5-7,9-11H2,(H2,21,24) ADLPAZXMBFTTEG-UHFFFAOYSA-N 309406 US9656962, Compound 31::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalene-2-carboxamide Mu-type opioid receptor Human 10.2 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309406&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699258 382365473 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593093 NC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H26N2O3/c21-18(24)14-9-19-5-6-22(11-12-1-2-12)17(20(19,25)10-14)7-13-3-4-15(23)8-16(13)19/h3-4,8,12,14,17,23,25H,1-2,5-7,9-11H2,(H2,21,24) ADLPAZXMBFTTEG-UHFFFAOYSA-N 309406 US9656962, Compound 31::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalene-2-carboxamide Kappa-type opioid receptor Human 0.840 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309406&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699258 382365473 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593094 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3ccccc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C27H32N2O3/c30-22-9-8-20-12-24-27(32)15-21(25(31)28-16-18-4-2-1-3-5-18)14-26(27,23(20)13-22)10-11-29(24)17-19-6-7-19/h1-5,8-9,13,19,21,24,30,32H,6-7,10-12,14-17H2,(H,28,31) UOCAMDNZRYYWSM-UHFFFAOYSA-N 309408 US9656962, Compound 33::(2R,3aS,4R,9bS)-N-benzyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Mu-type opioid receptor Human 1.39 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309408&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699213 382365475 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593095 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3ccccc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C27H32N2O3/c30-22-9-8-20-12-24-27(32)15-21(25(31)28-16-18-4-2-1-3-5-18)14-26(27,23(20)13-22)10-11-29(24)17-19-6-7-19/h1-5,8-9,13,19,21,24,30,32H,6-7,10-12,14-17H2,(H,28,31) UOCAMDNZRYYWSM-UHFFFAOYSA-N 309408 US9656962, Compound 33::(2R,3aS,4R,9bS)-N-benzyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Kappa-type opioid receptor Human 0.750 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309408&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699213 382365475 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593096 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCc3ccccc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C27H32N2O3/c30-22-9-8-20-12-24-27(32)15-21(25(31)28-16-18-4-2-1-3-5-18)14-26(27,23(20)13-22)10-11-29(24)17-19-6-7-19/h1-5,8-9,13,19,21,24,30,32H,6-7,10-12,14-17H2,(H,28,31) UOCAMDNZRYYWSM-UHFFFAOYSA-N 309411 US9656962, Compound 34::(2S,3aS,4R,9bS)-N-benzyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Kappa-type opioid receptor Human 0.083 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309411 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309411&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91810828 382365478 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593097 Cc1ccc(CNC(=O)[C@@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)cc1 |r,TLB:27:26:11:21.15.14| InChI=1S/C28H34N2O3/c1-18-2-4-19(5-3-18)16-29-26(32)22-14-27-10-11-30(17-20-6-7-20)25(28(27,33)15-22)12-21-8-9-23(31)13-24(21)27/h2-5,8-9,13,20,22,25,31,33H,6-7,10-12,14-17H2,1H3,(H,29,32) QOPVPTPMEYMTNK-UHFFFAOYSA-N 309413 US9656962, Compound 38::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(4-methylbenzyl)- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Kappa-type opioid receptor Human 0.160 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309413&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699264 382365480 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593098 Oc1ccc(CNC(=O)[C@@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)c(O)c1 |r,TLB:27:26:11:21.15.14| InChI=1S/C27H32N2O5/c30-20-5-3-17-9-24-27(34)13-19(25(33)28-14-18-4-6-21(31)11-23(18)32)12-26(27,22(17)10-20)7-8-29(24)15-16-1-2-16/h3-6,10-11,16,19,24,30-32,34H,1-2,7-9,12-15H2,(H,28,33) VPMOBDMYZKXITM-UHFFFAOYSA-N 309414 US9656962, Compound 42::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2,4-dihydroxybenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 0.400 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309414&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699235 382365481 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593099 Oc1ccc(CNC(=O)[C@@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)c(O)c1 |r,TLB:27:26:11:21.15.14| InChI=1S/C27H32N2O5/c30-20-5-3-17-9-24-27(34)13-19(25(33)28-14-18-4-6-21(31)11-23(18)32)12-26(27,22(17)10-20)7-8-29(24)15-16-1-2-16/h3-6,10-11,16,19,24,30-32,34H,1-2,7-9,12-15H2,(H,28,33) VPMOBDMYZKXITM-UHFFFAOYSA-N 309414 US9656962, Compound 42::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2,4-dihydroxybenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 0.370 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309414&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699235 382365481 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593100 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCCN3CCOCC3)c2c1 |r,TLB:8:7:18:31.4.5| InChI=1S/C26H37N3O4/c30-21-4-3-19-13-23-26(32)16-20(24(31)27-6-8-28-9-11-33-12-10-28)15-25(26,22(19)14-21)5-7-29(23)17-18-1-2-18/h3-4,14,18,20,23,30,32H,1-2,5-13,15-17H2,(H,27,31) WYFJHNJUNVPTFK-UHFFFAOYSA-N 309415 US9656962, Compound 93::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(2-morpholinoethyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 0.640 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309415&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699161 382365482 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593101 CN1CC[C@]23C[C@@H](C[C@@]2(O)[C@H]1Cc1ccc(O)cc31)C(=O)NCCc1ccccc1 |r,TLB:0:1:8:18.12.11| InChI=1S/C25H30N2O3/c1-27-12-10-24-15-19(23(29)26-11-9-17-5-3-2-4-6-17)16-25(24,30)22(27)13-18-7-8-20(28)14-21(18)24/h2-8,14,19,22,28,30H,9-13,15-16H2,1H3,(H,26,29) PUUKSWDVXBBVIG-UHFFFAOYSA-N 309416 US9656962, Compound 108::(2S,3aS,4R,9bS)-3a,8-dihydroxy-12- methyl-N-phenethyl-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)cyclo- penta[a]naphthalene-2-carboxamide Kappa-type opioid receptor Human 9.29 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309416&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699179 382365483 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593102 NC(=N)NCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:27:26:11:21.15.14| InChI=1S/C23H33N5O3/c24-21(25)27-7-6-26-20(30)16-11-22-5-8-28(13-14-1-2-14)19(23(22,31)12-16)9-15-3-4-17(29)10-18(15)22/h3-4,10,14,16,19,29,31H,1-2,5-9,11-13H2,(H,26,30)(H4,24,25,27) ZLARBRFVWKMWNZ-UHFFFAOYSA-N 309329 US9656962, Compound 6::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guanidinoethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309329 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309329&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699182 382365396 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593103 NC(=N)NCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:27:26:11:21.15.14| InChI=1S/C23H33N5O3/c24-21(25)27-7-6-26-20(30)16-11-22-5-8-28(13-14-1-2-14)19(23(22,31)12-16)9-15-3-4-17(29)10-18(15)22/h3-4,10,14,16,19,29,31H,1-2,5-9,11-13H2,(H,26,30)(H4,24,25,27) ZLARBRFVWKMWNZ-UHFFFAOYSA-N 309329 US9656962, Compound 6::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guanidinoethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 0.860 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309329 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309329&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699182 382365396 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593104 NC(=N)NCCCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:29:28:13:23.17.16| InChI=1S/C25H37N5O3/c26-23(27)29-9-2-1-8-28-22(32)18-13-24-7-10-30(15-16-3-4-16)21(25(24,33)14-18)11-17-5-6-19(31)12-20(17)24/h5-6,12,16,18,21,31,33H,1-4,7-11,13-15H2,(H,28,32)(H4,26,27,29) KKSGPBODUPPBKK-UHFFFAOYSA-N 309331 US9656962, Compound 7::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(4-guanidinobutyl)-3a,8-dibydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309331 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309331&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699261 382365398 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593105 NC(=N)NCCCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:29:28:13:23.17.16| InChI=1S/C25H37N5O3/c26-23(27)29-9-2-1-8-28-22(32)18-13-24-7-10-30(15-16-3-4-16)21(25(24,33)14-18)11-17-5-6-19(31)12-20(17)24/h5-6,12,16,18,21,31,33H,1-4,7-11,13-15H2,(H,28,32)(H4,26,27,29) KKSGPBODUPPBKK-UHFFFAOYSA-N 309331 US9656962, Compound 7::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(4-guanidinobutyl)-3a,8-dibydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 0.800 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309331 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309331&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699261 382365398 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593106 COC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,THB:22:21:6:16.10.9| 309366 US9656962, Compound 12::(2R,3aS,4R,9bS)-methyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxylate Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309366&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118198024 382365433 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593107 COC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,THB:22:21:6:16.10.9| 309366 US9656962, Compound 12::(2R,3aS,4R,9bS)-methyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxylate Kappa-type opioid receptor Human 2.95 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309366&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118198024 382365433 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593108 COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(O)=O)c2c1 |r,TLB:9:8:19:24.5.6| InChI=1S/C21H27NO4/c1-26-16-5-4-14-8-18-21(25)11-15(19(23)24)10-20(21,17(14)9-16)6-7-22(18)12-13-2-3-13/h4-5,9,13,15,18,25H,2-3,6-8,10-12H2,1H3,(H,23,24) JTWAFVOTKUBLIO-UHFFFAOYSA-N 309417 US9656962, Compound 15::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a-hydroxy-8-methoxy-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)- cyclopenta[a]naphthalene-2-carboxylic acid Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309417&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699244 382365484 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593109 OC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H25NO4/c22-15-4-3-13-7-17-20(25)10-14(18(23)24)9-19(20,16(13)8-15)5-6-21(17)11-12-1-2-12/h3-4,8,12,14,17,22,25H,1-2,5-7,9-11H2,(H,23,24) UNYTXCFUSXJNAQ-UHFFFAOYSA-N 309374 US9656962, Compound 16::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)-cyclopenta- [a]naphthalene-2-carboxylic acid Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309374&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699170 382365441 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593110 OC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H25NO4/c22-15-4-3-13-7-17-20(25)10-14(18(23)24)9-19(20,16(13)8-15)5-6-21(17)11-12-1-2-12/h3-4,8,12,14,17,22,25H,1-2,5-7,9-11H2,(H,23,24) UNYTXCFUSXJNAQ-UHFFFAOYSA-N 309374 US9656962, Compound 16::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)-cyclopenta- [a]naphthalene-2-carboxylic acid Kappa-type opioid receptor Human 12.4 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309374&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699170 382365441 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593111 N[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:19:18:3:13.7.6| InChI=1S/C19H26N2O2/c20-14-9-18-5-6-21(11-12-1-2-12)17(19(18,23)10-14)7-13-3-4-15(22)8-16(13)18/h3-4,8,12,14,17,22-23H,1-2,5-7,9-11,20H2 CRKOKOFIUAFPPC-UHFFFAOYSA-N 309418 US9656962, Compound 22::(2R,3aS,4R,9bS)-2-amino-12- (cyclopropylmethyl)-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)- cyclopenta[a]naphthalene-3a,8-diol Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309418&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 124082903 382365485 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593112 N[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:19:18:3:13.7.6| InChI=1S/C19H26N2O2/c20-14-9-18-5-6-21(11-12-1-2-12)17(19(18,23)10-14)7-13-3-4-15(22)8-16(13)18/h3-4,8,12,14,17,22-23H,1-2,5-7,9-11,20H2 CRKOKOFIUAFPPC-UHFFFAOYSA-N 309418 US9656962, Compound 22::(2R,3aS,4R,9bS)-2-amino-12- (cyclopropylmethyl)-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)- cyclopenta[a]naphthalene-3a,8-diol Kappa-type opioid receptor Human 25.7 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309418&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 124082903 382365485 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593113 COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C#N)c2c1 |r,TLB:9:8:19:23.5.6| InChI=1S/C21H26N2O2/c1-25-17-5-4-16-8-19-21(24)11-15(12-22)10-20(21,18(16)9-17)6-7-23(19)13-14-2-3-14/h4-5,9,14-15,19,24H,2-3,6-8,10-11,13H2,1H3 ITQRVVMIMRFNDD-UHFFFAOYSA-N 309419 US9656962, Compound 25::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a-hydroxy-8-methoxy-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)- cyclopenta[a]naphthalene-2-carbonitrile Mu-type opioid receptor Human 616 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309419&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699175 382365486 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593114 COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](N)C[C@@]34O)c2c1 |r,TLB:9:8:20:22.5.6| InChI=1S/C20H28N2O2/c1-24-16-5-4-14-8-18-20(23)11-15(21)10-19(20,17(14)9-16)6-7-22(18)12-13-2-3-13/h4-5,9,13,15,18,23H,2-3,6-8,10-12,21H2,1H3 VDBJTYZZSHFCET-UHFFFAOYSA-N 309420 US9656962, Compound 28::(2S,3aS,4R,9bS)-2-amino-12- (cyclopropylmethyl)-8-methoxy- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 3a-ol Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309420&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118204274 382365487 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593115 NC(=O)[C@@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H26N2O3/c21-18(24)14-9-19-5-6-22(11-12-1-2-12)17(20(19,25)10-14)7-13-3-4-15(23)8-16(13)19/h3-4,8,12,14,17,23,25H,1-2,5-7,9-11H2,(H2,21,24) ADLPAZXMBFTTEG-UHFFFAOYSA-N 309421 US9656962, Compound 30::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalene-2-carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309421&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118204386 382365488 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593116 NC(=O)[C@@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H26N2O3/c21-18(24)14-9-19-5-6-22(11-12-1-2-12)17(20(19,25)10-14)7-13-3-4-15(23)8-16(13)19/h3-4,8,12,14,17,23,25H,1-2,5-7,9-11H2,(H2,21,24) ADLPAZXMBFTTEG-UHFFFAOYSA-N 309421 US9656962, Compound 30::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalene-2-carboxamide Kappa-type opioid receptor Human 2.49 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309421&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118204386 382365488 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593117 NC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H26N2O3/c21-18(24)14-9-19-5-6-22(11-12-1-2-12)17(20(19,25)10-14)7-13-3-4-15(23)8-16(13)19/h3-4,8,12,14,17,23,25H,1-2,5-7,9-11H2,(H2,21,24) ADLPAZXMBFTTEG-UHFFFAOYSA-N 309406 US9656962, Compound 31::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalene-2-carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309406&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699258 382365473 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593118 NC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H26N2O3/c21-18(24)14-9-19-5-6-22(11-12-1-2-12)17(20(19,25)10-14)7-13-3-4-15(23)8-16(13)19/h3-4,8,12,14,17,23,25H,1-2,5-7,9-11H2,(H2,21,24) ADLPAZXMBFTTEG-UHFFFAOYSA-N 309406 US9656962, Compound 31::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalene-2-carboxamide Kappa-type opioid receptor Human 6.95 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309406&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699258 382365473 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593119 NC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:21:20:5:15.9.8| InChI=1S/C20H26N2O3/c21-18(24)14-9-19-5-6-22(11-12-1-2-12)17(20(19,25)10-14)7-13-3-4-15(23)8-16(13)19/h3-4,8,12,14,17,23,25H,1-2,5-7,9-11H2,(H2,21,24) ADLPAZXMBFTTEG-UHFFFAOYSA-N 309406 US9656962, Compound 31::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalene-2-carboxamide Delta-type opioid receptor Human 75.5 US Patent 10.7270/Q2K076BH aid1796245 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309406&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699258 382365473 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 593120 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3ccccc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C27H32N2O3/c30-22-9-8-20-12-24-27(32)15-21(25(31)28-16-18-4-2-1-3-5-18)14-26(27,23(20)13-22)10-11-29(24)17-19-6-7-19/h1-5,8-9,13,19,21,24,30,32H,6-7,10-12,14-17H2,(H,28,31) UOCAMDNZRYYWSM-UHFFFAOYSA-N 309408 US9656962, Compound 33::(2R,3aS,4R,9bS)-N-benzyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309408&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699213 382365475 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593121 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3ccccc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C27H32N2O3/c30-22-9-8-20-12-24-27(32)15-21(25(31)28-16-18-4-2-1-3-5-18)14-26(27,23(20)13-22)10-11-29(24)17-19-6-7-19/h1-5,8-9,13,19,21,24,30,32H,6-7,10-12,14-17H2,(H,28,31) UOCAMDNZRYYWSM-UHFFFAOYSA-N 309408 US9656962, Compound 33::(2R,3aS,4R,9bS)-N-benzyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Kappa-type opioid receptor Human 7.03 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309408&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699213 382365475 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593122 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCc3ccccc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C27H32N2O3/c30-22-9-8-20-12-24-27(32)15-21(25(31)28-16-18-4-2-1-3-5-18)14-26(27,23(20)13-22)10-11-29(24)17-19-6-7-19/h1-5,8-9,13,19,21,24,30,32H,6-7,10-12,14-17H2,(H,28,31) UOCAMDNZRYYWSM-UHFFFAOYSA-N 309411 US9656962, Compound 34::(2S,3aS,4R,9bS)-N-benzyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Mu-type opioid receptor Human 3.75 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309411 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309411&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91810828 382365478 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593123 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCc3ccccc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C27H32N2O3/c30-22-9-8-20-12-24-27(32)15-21(25(31)28-16-18-4-2-1-3-5-18)14-26(27,23(20)13-22)10-11-29(24)17-19-6-7-19/h1-5,8-9,13,19,21,24,30,32H,6-7,10-12,14-17H2,(H,28,31) UOCAMDNZRYYWSM-UHFFFAOYSA-N 309411 US9656962, Compound 34::(2S,3aS,4R,9bS)-N-benzyl-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Kappa-type opioid receptor Human 0.094 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309411 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309411&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 91810828 382365478 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593124 CC(C)CNC(=O)[C@@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:25:24:9:19.13.12| InChI=1S/C24H34N2O3/c1-15(2)13-25-22(28)18-11-23-7-8-26(14-16-3-4-16)21(24(23,29)12-18)9-17-5-6-19(27)10-20(17)23/h5-6,10,15-16,18,21,27,29H,3-4,7-9,11-14H2,1-2H3,(H,25,28) GHRGHWZSSHUFPM-UHFFFAOYSA-N 309422 US9656962, Compound 36::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-isobutyl-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)- cyclopenta[a]naphthalene-2-carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309422&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699216 382365489 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593125 CC(C)CNC(=O)[C@@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:25:24:9:19.13.12| InChI=1S/C24H34N2O3/c1-15(2)13-25-22(28)18-11-23-7-8-26(14-16-3-4-16)21(24(23,29)12-18)9-17-5-6-19(27)10-20(17)23/h5-6,10,15-16,18,21,27,29H,3-4,7-9,11-14H2,1-2H3,(H,25,28) GHRGHWZSSHUFPM-UHFFFAOYSA-N 309422 US9656962, Compound 36::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-isobutyl-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)- cyclopenta[a]naphthalene-2-carboxamide Kappa-type opioid receptor Human 2.24 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309422&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699216 382365489 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593126 Cc1ccc(CNC(=O)[C@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)cc1 |r,TLB:27:26:11:21.15.14| InChI=1S/C28H34N2O3/c1-18-2-4-19(5-3-18)16-29-26(32)22-14-27-10-11-30(17-20-6-7-20)25(28(27,33)15-22)12-21-8-9-23(31)13-24(21)27/h2-5,8-9,13,20,22,25,31,33H,6-7,10-12,14-17H2,1H3,(H,29,32) QOPVPTPMEYMTNK-UHFFFAOYSA-N 309423 US9656962, Compound 37::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(4-methylbenzyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309423&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699159 382365490 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593127 Cc1ccc(CNC(=O)[C@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)cc1 |r,TLB:27:26:11:21.15.14| InChI=1S/C28H34N2O3/c1-18-2-4-19(5-3-18)16-29-26(32)22-14-27-10-11-30(17-20-6-7-20)25(28(27,33)15-22)12-21-8-9-23(31)13-24(21)27/h2-5,8-9,13,20,22,25,31,33H,6-7,10-12,14-17H2,1H3,(H,29,32) QOPVPTPMEYMTNK-UHFFFAOYSA-N 309423 US9656962, Compound 37::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(4-methylbenzyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 1.74 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309423&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699159 382365490 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593128 Cc1ccc(CNC(=O)[C@@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)cc1 |r,TLB:27:26:11:21.15.14| InChI=1S/C28H34N2O3/c1-18-2-4-19(5-3-18)16-29-26(32)22-14-27-10-11-30(17-20-6-7-20)25(28(27,33)15-22)12-21-8-9-23(31)13-24(21)27/h2-5,8-9,13,20,22,25,31,33H,6-7,10-12,14-17H2,1H3,(H,29,32) QOPVPTPMEYMTNK-UHFFFAOYSA-N 309413 US9656962, Compound 38::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(4-methylbenzyl)- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Mu-type opioid receptor Human 0.620 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309413&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699264 382365480 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593129 Cc1ccc(CNC(=O)[C@@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)cc1 |r,TLB:27:26:11:21.15.14| InChI=1S/C28H34N2O3/c1-18-2-4-19(5-3-18)16-29-26(32)22-14-27-10-11-30(17-20-6-7-20)25(28(27,33)15-22)12-21-8-9-23(31)13-24(21)27/h2-5,8-9,13,20,22,25,31,33H,6-7,10-12,14-17H2,1H3,(H,29,32) QOPVPTPMEYMTNK-UHFFFAOYSA-N 309413 US9656962, Compound 38::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(4-methylbenzyl)- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Kappa-type opioid receptor Human 0.430 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309413&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699264 382365480 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593130 Cc1ccc(CNC(=O)[C@@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)cc1 |r,TLB:27:26:11:21.15.14| InChI=1S/C28H34N2O3/c1-18-2-4-19(5-3-18)16-29-26(32)22-14-27-10-11-30(17-20-6-7-20)25(28(27,33)15-22)12-21-8-9-23(31)13-24(21)27/h2-5,8-9,13,20,22,25,31,33H,6-7,10-12,14-17H2,1H3,(H,29,32) QOPVPTPMEYMTNK-UHFFFAOYSA-N 309413 US9656962, Compound 38::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(4-methylbenzyl)- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Delta-type opioid receptor Human 1.56 US Patent 10.7270/Q2K076BH aid1796245 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309413&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699264 382365480 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 593131 Oc1ccc(CNC(=O)[C@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)cc1 |r,TLB:27:26:11:21.15.14| InChI=1S/C27H32N2O4/c30-21-6-3-17(4-7-21)15-28-25(32)20-13-26-9-10-29(16-18-1-2-18)24(27(26,33)14-20)11-19-5-8-22(31)12-23(19)26/h3-8,12,18,20,24,30-31,33H,1-2,9-11,13-16H2,(H,28,32) DQKYLGASGSMNHK-UHFFFAOYSA-N 309424 US9656962, Compound 39::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(4-hydroxybenzyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 37.5 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309424&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699168 382365491 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593132 Oc1ccc(CNC(=O)[C@@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)cc1 |r,TLB:27:26:11:21.15.14| InChI=1S/C27H32N2O4/c30-21-6-3-17(4-7-21)15-28-25(32)20-13-26-9-10-29(16-18-1-2-18)24(27(26,33)14-20)11-19-5-8-22(31)12-23(19)26/h3-8,12,18,20,24,30-31,33H,1-2,9-11,13-16H2,(H,28,32) DQKYLGASGSMNHK-UHFFFAOYSA-N 309425 US9656962, Compound 40::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(4-hydroxybenzyl)- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309425&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699196 382365492 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593133 Oc1ccc(CNC(=O)[C@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)c(O)c1 |r,TLB:27:26:11:21.15.14| InChI=1S/C27H32N2O5/c30-20-5-3-17-9-24-27(34)13-19(25(33)28-14-18-4-6-21(31)11-23(18)32)12-26(27,22(17)10-20)7-8-29(24)15-16-1-2-16/h3-6,10-11,16,19,24,30-32,34H,1-2,7-9,12-15H2,(H,28,33) VPMOBDMYZKXITM-UHFFFAOYSA-N 309426 US9656962, Compound 41::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2,4-dihydroxybenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309426 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309426&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699212 382365493 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593134 Oc1ccc(CNC(=O)[C@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)c(O)c1 |r,TLB:27:26:11:21.15.14| InChI=1S/C27H32N2O5/c30-20-5-3-17-9-24-27(34)13-19(25(33)28-14-18-4-6-21(31)11-23(18)32)12-26(27,22(17)10-20)7-8-29(24)15-16-1-2-16/h3-6,10-11,16,19,24,30-32,34H,1-2,7-9,12-15H2,(H,28,33) VPMOBDMYZKXITM-UHFFFAOYSA-N 309426 US9656962, Compound 41::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2,4-dihydroxybenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 1.74 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309426 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309426&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699212 382365493 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593135 Oc1ccc(CNC(=O)[C@@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)c(O)c1 |r,TLB:27:26:11:21.15.14| InChI=1S/C27H32N2O5/c30-20-5-3-17-9-24-27(34)13-19(25(33)28-14-18-4-6-21(31)11-23(18)32)12-26(27,22(17)10-20)7-8-29(24)15-16-1-2-16/h3-6,10-11,16,19,24,30-32,34H,1-2,7-9,12-15H2,(H,28,33) VPMOBDMYZKXITM-UHFFFAOYSA-N 309414 US9656962, Compound 42::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2,4-dihydroxybenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309414&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699235 382365481 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593136 Oc1ccc(CNC(=O)[C@@H]2C[C@@]3(O)[C@H]4Cc5ccc(O)cc5[C@]3(C2)CCN4CC2CC2)c(O)c1 |r,TLB:27:26:11:21.15.14| InChI=1S/C27H32N2O5/c30-20-5-3-17-9-24-27(34)13-19(25(33)28-14-18-4-6-21(31)11-23(18)32)12-26(27,22(17)10-20)7-8-29(24)15-16-1-2-16/h3-6,10-11,16,19,24,30-32,34H,1-2,7-9,12-15H2,(H,28,33) VPMOBDMYZKXITM-UHFFFAOYSA-N 309414 US9656962, Compound 42::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2,4-dihydroxybenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 0.320 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309414&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699235 382365481 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593137 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3ccc(Cl)cc3)c2c1 |r,TLB:8:7:18:31.4.5| InChI=1S/C27H31ClN2O3/c28-21-6-3-17(4-7-21)15-29-25(32)20-13-26-9-10-30(16-18-1-2-18)24(27(26,33)14-20)11-19-5-8-22(31)12-23(19)26/h3-8,12,18,20,24,31,33H,1-2,9-11,13-16H2,(H,29,32) VLVUNSSOWNYWAG-UHFFFAOYSA-N 309427 US9656962, Compound 43::(2R,3aS,4R,9bS)-N-(4-chlorobenzyl)-12- (cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 8.35 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309427 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309427&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699171 382365494 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593138 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCc3ccc(Cl)cc3Cl)c2c1 |r,TLB:8:7:18:32.4.5| InChI=1S/C27H30Cl2N2O3/c28-20-5-3-18(23(29)10-20)14-30-25(33)19-12-26-7-8-31(15-16-1-2-16)24(27(26,34)13-19)9-17-4-6-21(32)11-22(17)26/h3-6,10-11,16,19,24,32,34H,1-2,7-9,12-15H2,(H,30,33) WSLIEDMZWMXUFX-UHFFFAOYSA-N 309429 US9656962, Compound 45::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2,4-dichlorobenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 0.380 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309429 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309429&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699254 382365496 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593139 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3ccc(Cl)c(Cl)c3)c2c1 |r,TLB:8:7:18:32.4.5| InChI=1S/C27H30Cl2N2O3/c28-22-6-3-17(9-23(22)29)14-30-25(33)19-12-26-7-8-31(15-16-1-2-16)24(27(26,34)13-19)10-18-4-5-20(32)11-21(18)26/h3-6,9,11,16,19,24,32,34H,1-2,7-8,10,12-15H2,(H,30,33) CVTHHKMXXKHSLK-UHFFFAOYSA-N 309430 US9656962, Compound 46::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(3,4-dichlorobenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309430 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309430&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699230 382365497 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593140 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3ccc(Cl)c(Cl)c3)c2c1 |r,TLB:8:7:18:32.4.5| InChI=1S/C27H30Cl2N2O3/c28-22-6-3-17(9-23(22)29)14-30-25(33)19-12-26-7-8-31(15-16-1-2-16)24(27(26,34)13-19)10-18-4-5-20(32)11-21(18)26/h3-6,9,11,16,19,24,32,34H,1-2,7-8,10,12-15H2,(H,30,33) CVTHHKMXXKHSLK-UHFFFAOYSA-N 309430 US9656962, Compound 46::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(3,4-dichlorobenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 0.200 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309430 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309430&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699230 382365497 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593141 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCc3ccc(Cl)c(Cl)c3)c2c1 |r,TLB:8:7:18:32.4.5| InChI=1S/C27H30Cl2N2O3/c28-22-6-3-17(9-23(22)29)14-30-25(33)19-12-26-7-8-31(15-16-1-2-16)24(27(26,34)13-19)10-18-4-5-20(32)11-21(18)26/h3-6,9,11,16,19,24,32,34H,1-2,7-8,10,12-15H2,(H,30,33) CVTHHKMXXKHSLK-UHFFFAOYSA-N 309432 US9656962, Compound 47::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(3,4-dichlorobenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 2.76 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309432&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699262 382365499 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593142 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCc3ccc(Cl)c(Cl)c3)c2c1 |r,TLB:8:7:18:32.4.5| InChI=1S/C27H30Cl2N2O3/c28-22-6-3-17(9-23(22)29)14-30-25(33)19-12-26-7-8-31(15-16-1-2-16)24(27(26,34)13-19)10-18-4-5-20(32)11-21(18)26/h3-6,9,11,16,19,24,32,34H,1-2,7-8,10,12-15H2,(H,30,33) CVTHHKMXXKHSLK-UHFFFAOYSA-N 309432 US9656962, Compound 47::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(3,4-dichlorobenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 0.030 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309432&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699262 382365499 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593143 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3ccc(F)cc3)c2c1 |r,TLB:8:7:18:31.4.5| InChI=1S/C27H31FN2O3/c28-21-6-3-17(4-7-21)15-29-25(32)20-13-26-9-10-30(16-18-1-2-18)24(27(26,33)14-20)11-19-5-8-22(31)12-23(19)26/h3-8,12,18,20,24,31,33H,1-2,9-11,13-16H2,(H,29,32) SAZYSHYLLQGZMH-UHFFFAOYSA-N 309434 US9656962, Compound 48::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(4-fluorobenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309434&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699260 382365501 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593144 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3cc(F)cc(F)c3)c2c1 |r,TLB:8:7:18:32.4.5| InChI=1S/C27H30F2N2O3/c28-20-7-17(8-21(29)10-20)14-30-25(33)19-12-26-5-6-31(15-16-1-2-16)24(27(26,34)13-19)9-18-3-4-22(32)11-23(18)26/h3-4,7-8,10-11,16,19,24,32,34H,1-2,5-6,9,12-15H2,(H,30,33) DJBXERFZZGRLDE-UHFFFAOYSA-N 309437 US9656962, Compound 49::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(3,5-difluorobenzyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 6.17 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309437&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699214 382365504 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593145 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCCc3ccccc3)c2c1 |r,TLB:8:7:18:31.4.5| InChI=1S/C28H34N2O3/c31-23-9-8-21-14-25-28(33)17-22(26(32)29-12-10-19-4-2-1-3-5-19)16-27(28,24(21)15-23)11-13-30(25)18-20-6-7-20/h1-5,8-9,15,20,22,25,31,33H,6-7,10-14,16-18H2,(H,29,32) JTLDRMWIUBYHPV-UHFFFAOYSA-N 309439 US9656962, Compound 51::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-phenethyl-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)cyclo- penta[a]naphthalene-2-carboxamide Mu-type opioid receptor Human 0.490 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309439&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699154 382365506 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593146 NC(=O)CNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1 |r,TLB:25:24:9:19.13.12| InChI=1S/C22H29N3O4/c23-19(27)11-24-20(28)15-9-21-5-6-25(12-13-1-2-13)18(22(21,29)10-15)7-14-3-4-16(26)8-17(14)21/h3-4,8,13,15,18,26,29H,1-2,5-7,9-12H2,(H2,23,27)(H,24,28) GICDVLATHYGMOT-UHFFFAOYSA-N 309440 US9656962, Compound 64::(2R,3aS,4R,9bS)-N-(2-amino-2-oxoethyl)- 12-(cyclopropylmethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309440&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699217 382365507 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593147 CN1CC[C@]23C[C@H](C[C@@]2(O)[C@H]1Cc1ccc(O)cc31)C(N)=O |r,TLB:0:1:8:18.12.11| InChI=1S/C17H22N2O3/c1-19-5-4-16-8-11(15(18)21)9-17(16,22)14(19)6-10-2-3-12(20)7-13(10)16/h2-3,7,11,14,20,22H,4-6,8-9H2,1H3,(H2,18,21) VQPNOAFRRUNABV-UHFFFAOYSA-N 309441 US9656962, Compound 77::(2R,3aS,4R,9bS)-3a,8-dihydroxy-12- methyl-1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta[a]naphthalene- 2-carboxamide Mu-type opioid receptor Human 580 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309441&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699267 382365508 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593148 CN1CC[C@]23C[C@@H](C[C@@]2(O)[C@H]1Cc1ccc(O)cc31)C(N)=O |r,TLB:0:1:8:18.12.11| InChI=1S/C17H22N2O3/c1-19-5-4-16-8-11(15(18)21)9-17(16,22)14(19)6-10-2-3-12(20)7-13(10)16/h2-3,7,11,14,20,22H,4-6,8-9H2,1H3,(H2,18,21) VQPNOAFRRUNABV-UHFFFAOYSA-N 309443 US9656962, Compound 78::(2S,3aS,4R,9bS)-3a,8-dihydroxy-12- methyl-1,2,3,3a,4,5-hexahydro-4,9b- (epiminoethano)cyclopenta- [a]naphthalene-2-carboxamide Mu-type opioid receptor Human 308 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309443 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309443&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699194 382365510 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593149 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)NC(=O)c3ccccc3)c2c1 |r,TLB:8:7:18:29.4.5| InChI=1S/C26H30N2O3/c29-21-9-8-19-12-23-26(31)15-20(27-24(30)18-4-2-1-3-5-18)14-25(26,22(19)13-21)10-11-28(23)16-17-6-7-17/h1-5,8-9,13,17,20,23,29,31H,6-7,10-12,14-16H2,(H,27,30) IINIOVKJVQYWEP-UHFFFAOYSA-N 309444 US9656962, Compound 79::N-((2S,3aS,4R,9bS)-12-(cyclopropyl- methyl)-3a,8-dihydroxy-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)cyclo- penta[a]naphthalen-2-yl)benzamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309444&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 124082913 382365511 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593150 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)NCc3ccccc3)c2c1 |r,TLB:8:7:18:28.4.5| InChI=1S/C26H32N2O2/c29-22-9-8-20-12-24-26(30)15-21(27-16-18-4-2-1-3-5-18)14-25(26,23(20)13-22)10-11-28(24)17-19-6-7-19/h1-5,8-9,13,19,21,24,27,29-30H,6-7,10-12,14-17H2 RIQJVMQSRGCMAD-UHFFFAOYSA-N 309445 US9656962, Compound 80::(2R,3aS,4R,9bS)-2-(benzylamino)-12- (cyclopropylmethyl)-2,3,4,5- tetrahydro-4,9b-(epiminoethano)- cyclopenta-[a]naphthalene-3a,8(1H)- diol Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309445&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 124082914 382365512 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593151 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)N(Cc3ccccc3)Cc3ccccc3)c2c1 |r,TLB:8:7:18:35.4.5| InChI=1S/C33H38N2O2/c36-29-14-13-27-17-31-33(37)20-28(19-32(33,30(27)18-29)15-16-34(31)21-26-11-12-26)35(22-24-7-3-1-4-8-24)23-25-9-5-2-6-10-25/h1-10,13-14,18,26,28,31,36-37H,11-12,15-17,19-23H2 MHHGWJRPGOHVEW-UHFFFAOYSA-N 309446 US9656962, Compound 81::(2R,3aS,4R,9bS)-12-(cyclopropyl- methyl)-2-(dibenzylamino)-2,3,4,5- tetrahydro-4,9b-(epiminoethano)- cyclopenta-[a]naphthalene-3a,8(1H)- diol Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309446&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 124082916 382365513 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593152 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)NC(=O)c3ccccc3)c2c1 |r,TLB:8:7:18:29.4.5| InChI=1S/C26H30N2O3/c29-21-9-8-19-12-23-26(31)15-20(27-24(30)18-4-2-1-3-5-18)14-25(26,22(19)13-21)10-11-28(23)16-17-6-7-17/h1-5,8-9,13,17,20,23,29,31H,6-7,10-12,14-16H2,(H,27,30) IINIOVKJVQYWEP-UHFFFAOYSA-N 309447 US9656962, Compound 82::N-((2R,3aS,4R,9bS)-12-(cyclopropyl- methyl)-3a,8-dihydroxy-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)cyclo- penta[a]naphthalen-2-yl)benzamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309447&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 124082915 382365514 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593153 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)NC(=O)Nc3ccccc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C26H31N3O3/c30-21-9-8-18-12-23-26(32)15-20(28-24(31)27-19-4-2-1-3-5-19)14-25(26,22(18)13-21)10-11-29(23)16-17-6-7-17/h1-5,8-9,13,17,20,23,30,32H,6-7,10-12,14-16H2,(H2,27,28,31) BOEOXMTUKUEXOM-UHFFFAOYSA-N 309448 US9656962, Compound 83::1-((2R,3aS,4R,9bS)-12-(cyclopropyl- methyl)-3a,8-dihydroxy-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)cyclo- penta[a]naphthalen-2-yl)-3-phenylurea Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309448&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 124082917 382365515 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593154 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCCN3CCOCC3)c2c1 |r,TLB:8:7:18:31.4.5| InChI=1S/C26H37N3O4/c30-21-4-3-19-13-23-26(32)16-20(24(31)27-6-8-28-9-11-33-12-10-28)15-25(26,22(19)14-21)5-7-29(23)17-18-1-2-18/h3-4,14,18,20,23,30,32H,1-2,5-13,15-17H2,(H,27,31) WYFJHNJUNVPTFK-UHFFFAOYSA-N 309449 US9656962, Compound 84::(2R,3aS,4R,9bS)-12-(cyclopropyl- methyl)-3a,8-dihydroxy-N-(2- morpholinoethyl)-1,2,3,3a,4,5- hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 71.7 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309449&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699156 382365516 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593155 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCCCN3CCOCC3)c2c1 |r,TLB:8:7:18:32.4.5| InChI=1S/C27H39N3O4/c31-22-5-4-20-14-24-27(33)17-21(25(32)28-7-1-8-29-10-12-34-13-11-29)16-26(27,23(20)15-22)6-9-30(24)18-19-2-3-19/h4-5,15,19,21,24,31,33H,1-3,6-14,16-18H2,(H,28,32) BMEPVICFWOSVJG-UHFFFAOYSA-N 309450 US9656962, Compound 85::(2R,3aS,4R,9bS)-12-(cyclopropyl- methyl)-3a,8-dihydroxy-N-(3- morpholinopropyl)-1,2,3,3a,4,5- hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309450&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699224 382365517 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593156 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)N3CCN(CC3)c3ccccc3)c2c1 |r,TLB:8:7:18:34.4.5| InChI=1S/C30H37N3O3/c34-25-9-8-22-16-27-30(36)19-23(18-29(30,26(22)17-25)10-11-33(27)20-21-6-7-21)28(35)32-14-12-31(13-15-32)24-4-2-1-3-5-24/h1-5,8-9,17,21,23,27,34,36H,6-7,10-16,18-20H2 FLSLZOHARNLOGA-UHFFFAOYSA-N 309451 US9656962, Compound 86::((2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalen-2-yl)(4-phenylpiperazin-1- yl)methanone Mu-type opioid receptor Human 28.8 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309451&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699199 382365518 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593157 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)N3CCSCC3)c2c1 |r,TLB:8:7:18:28.4.5| InChI=1S/C24H32N2O3S/c27-19-4-3-17-11-21-24(29)14-18(22(28)25-7-9-30-10-8-25)13-23(24,20(17)12-19)5-6-26(21)15-16-1-2-16/h3-4,12,16,18,21,27,29H,1-2,5-11,13-15H2 RRKPPQPOEMIKNC-UHFFFAOYSA-N 309452 US9656962, Compound 87::((2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalen-2-yl)(thiomorpholino)- methanone Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309452&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699164 382365519 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593158 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)N3CCC(CC3)N3CCCC3)c2c1 |r,TLB:8:7:18:33.4.5| InChI=1S/C29H41N3O3/c33-24-6-5-21-15-26-29(35)18-22(27(34)31-12-7-23(8-13-31)30-10-1-2-11-30)17-28(29,25(21)16-24)9-14-32(26)19-20-3-4-20/h5-6,16,20,22-23,26,33,35H,1-4,7-15,17-19H2 NIUCCJXFAJTLIP-UHFFFAOYSA-N 309453 US9656962, Compound 88::((2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalen-2-yl)(4-(pyrrolidin-1- yl)piperidin-1-yl)methanone Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309453 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309453&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699240 382365520 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593159 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3cccnc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C26H31N3O3/c30-21-6-5-19-10-23-26(32)13-20(24(31)28-15-18-2-1-8-27-14-18)12-25(26,22(19)11-21)7-9-29(23)16-17-3-4-17/h1-2,5-6,8,11,14,17,20,23,30,32H,3-4,7,9-10,12-13,15-16H2,(H,28,31) FBNMHXTVRPMBRZ-UHFFFAOYSA-N 309454 US9656962, Compound 89::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(pyridin-3-ylmethyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309454&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699249 382365521 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593160 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(=O)NCc3ccncc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C26H31N3O3/c30-21-4-3-19-11-23-26(32)14-20(24(31)28-15-17-5-8-27-9-6-17)13-25(26,22(19)12-21)7-10-29(23)16-18-1-2-18/h3-6,8-9,12,18,20,23,30,32H,1-2,7,10-11,13-16H2,(H,28,31) CDSZLMHOSVHPRO-UHFFFAOYSA-N 309455 US9656962, Compound 90::(2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(pyridin-4-ylmethyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309455&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699173 382365522 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593161 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCCCN3CCOCC3)c2c1 |r,TLB:8:7:18:32.4.5| InChI=1S/C27H39N3O4/c31-22-5-4-20-14-24-27(33)17-21(25(32)28-7-1-8-29-10-12-34-13-11-29)16-26(27,23(20)15-22)6-9-30(24)18-19-2-3-19/h4-5,15,19,21,24,31,33H,1-3,6-14,16-18H2,(H,28,32) BMEPVICFWOSVJG-UHFFFAOYSA-N 309456 US9656962, Compound 91::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(3-morpholinopropyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309456&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699204 382365523 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593162 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCc3cccnc3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C26H31N3O3/c30-21-6-5-19-10-23-26(32)13-20(24(31)28-15-18-2-1-8-27-14-18)12-25(26,22(19)11-21)7-9-29(23)16-17-3-4-17/h1-2,5-6,8,11,14,17,20,23,30,32H,3-4,7,9-10,12-13,15-16H2,(H,28,31) FBNMHXTVRPMBRZ-UHFFFAOYSA-N 309457 US9656962, Compound 92::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(pyridin-3-ylmethyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309457&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699153 382365524 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593163 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCCN3CCOCC3)c2c1 |r,TLB:8:7:18:31.4.5| InChI=1S/C26H37N3O4/c30-21-4-3-19-13-23-26(32)16-20(24(31)27-6-8-28-9-11-33-12-10-28)15-25(26,22(19)14-21)5-7-29(23)17-18-1-2-18/h3-4,14,18,20,23,30,32H,1-2,5-13,15-17H2,(H,27,31) WYFJHNJUNVPTFK-UHFFFAOYSA-N 309415 US9656962, Compound 93::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(2-morpholinoethyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Mu-type opioid receptor Human 3.95 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309415&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699161 382365482 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 593164 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)NCCN3CCOCC3)c2c1 |r,TLB:8:7:18:31.4.5| InChI=1S/C26H37N3O4/c30-21-4-3-19-13-23-26(32)16-20(24(31)27-6-8-28-9-11-33-12-10-28)15-25(26,22(19)14-21)5-7-29(23)17-18-1-2-18/h3-4,14,18,20,23,30,32H,1-2,5-13,15-17H2,(H,27,31) WYFJHNJUNVPTFK-UHFFFAOYSA-N 309415 US9656962, Compound 93::(2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-N-(2-morpholinoethyl)- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide Kappa-type opioid receptor Human 1.52 US Patent 10.7270/Q2K076BH aid1796244 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309415&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699161 382365482 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 593165 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@@H](C[C@@]34O)C(=O)N3CCS(=O)(=O)CC3)c2c1 |r,TLB:8:7:18:30.4.5| InChI=1S/C24H32N2O5S/c27-19-4-3-17-11-21-24(29)14-18(22(28)25-7-9-32(30,31)10-8-25)13-23(24,20(17)12-19)5-6-26(21)15-16-1-2-16/h3-4,12,16,18,21,27,29H,1-2,5-11,13-15H2 WTYAAGFZAVIHLI-UHFFFAOYSA-N 309458 US9656962, Compound 94::((2S,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a,8-dihydroxy-1,2,3,3a,4,5-hexahydro- 4,9b-(epiminoethano)cyclopenta- [a]naphthalen-2-yl)(1,1-dioxido- thiomorpholino)methanone Mu-type opioid receptor Human >20000 US Patent 10.7270/Q2K076BH aid1796243 US9656962 Lockman, J; Tafesse, L 5/23/2017 4/8/2019 Purdue Pharma http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=309458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=309458&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 122699215 382365525 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57